About Ubenwa
Ubenwa is a company based in Montreal-est (Canada) founded in 2019. Ubenwa has raised $2.5 million across 1 funding round from investors including Radical Ventures, AIX Ventures and Pieter Abbeel. Ubenwa offers products and services including Get Nanni, Get Roseline, and API Integrations. Ubenwa operates in a competitive market with competitors including Medsensio, Docturnal, RESPINOR, Ibrum Technologies and ResApp Health, among others.
- Headquarter Montreal-est, Canada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ubenwa Intelligence Solutions Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.5 M (USD)
in 1 rounds
-
Latest Funding Round
$2.5 M (USD), Seed
Jul 25, 2022
-
Investors
Radical Ventures
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ubenwa
Ubenwa offers a comprehensive portfolio of products and services, including Get Nanni, Get Roseline, and API Integrations.
AI app for analyzing baby cries to detect health indicators.
App for voice-based insights in healthcare monitoring.
APIs for cry analysis in custom health applications.
People of Ubenwa
Unlock access to complete
Unlock access to complete
Funding Insights of Ubenwa
Ubenwa has successfully raised a total of $2.5M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.5 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ubenwa
Ubenwa has secured backing from 7 investors, including venture fund and angel investors. Prominent investors backing the company include Radical Ventures, AIX Ventures and Pieter Abbeel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on AI-driven companies
|
Locked | Locked | Locked | |
|
Venture capital is provided to AI-powered companies by AIX Ventures.
|
Locked | Locked | Locked | |
|
PA
Pieter Abbeel |
AI researcher, UC Berkeley professor, and angel investor in tech startups
|
Locked | Locked | Locked |
Investor details for Ubenwa
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ubenwa
Investment portfolio details for Ubenwa
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ubenwa
Detailed financials for Ubenwa
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ubenwa Comparisons
Peer comparison for Ubenwa
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ubenwa
Ubenwa operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medsensio, Docturnal, RESPINOR, Ibrum Technologies and ResApp Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Respiratory diagnostics are enhanced via a deep learning platform.
|
|
| Locked | Locked | Locked |
Non-invasive solutions for tuberculosis detection and diagnostics are provided.
|
|
| Locked | Locked | Locked |
Real-time diaphragm monitoring devices are provided for medical decision making.
|
|
| Locked | Locked | Locked |
Devices for detecting undiagnosed cardiac and respiratory diseases are developed.
|
|
| Locked | Locked | Locked |
Respiratory diseases are diagnosed digitally from cough and breathing sounds.
|
|
| Locked | Locked | Locked |
Software for sound based cardiopulmonary disease diagnosis
|
Detailed competitors of Ubenwa
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ubenwa
Complete news archive for Ubenwa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ubenwa
Ubenwa was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Ubenwa is headquartered in Montreal-est, Canada. It is registered at Montreal-est, Quebec, Canada.
Ubenwa is a funded company, having raised a total of $2.5M across 1 funding round to date.
Ubenwa was founded in 2019 in Montreal Est, Canada, within the health technology sector. A mobile software platform is operated to support neonatal diagnostics. Infant cries are intake and analyzed through machine learning algorithms, with focus on amplitude to provide insights for birth asphyxia identification. Services target early detection in newborn care, serving healthcare applications across relevant geographies.
Ubenwa offers Get Nanni, Get Roseline, and API Integrations.
Ubenwa has 7 investors. Key investors include Radical Ventures, AIX Ventures, Pieter Abbeel, Richard Socher, and Yoshua Bengio.